GINWA(600080)
Search documents
金花股份(600080.SH):首次减持2万股已回购股份
Ge Long Hui A P P· 2026-02-13 08:19
格隆汇2月13日丨金花股份(维权)(600080.SH)公布,2026 年2月11日,公司通过集中竞价交易方式首 次减持已回购股份2万股,占公司总股本的0.0054%,减持均价8.45元/股,成交总金额为人民币16.9万元 (不含印花税、交易佣金等交易费用)。本次减持后,公司回购专用证券账户持有股份2053.76万股, 占公司总股本的5.50%。本次减持符合公司既定的减持计划,符合《上海证券交易所上市公司自律监管 指引第7号——回购股份》等相关规定。 ...
金花股份(600080) - 金花企业(集团)股份有限公司关于首次集中竞价减持已回购股份的进展公告
2026-02-13 08:01
本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 证券代码:600080 证券简称:金花股份 公告编号:2026-006 金花企业(集团)股份有限公司 关于首次集中竞价减持已回购股份的进展公告 重要内容提示: 回购股份的基本情况 金花企业(集团)股份有限公司 (以下简称"公司")于 2024 年 2 月 23 日至2024年5月22日期间通过集中竞价交易方式累计回购公司股份20,557,582 股,占公司总股本的 5.51%。其中,用于员工持股计划或股权激励累计回购股份 2,750,000 股(占公司总股本 0.74%);用于维护公司价值及股东权益累计回购股 份 17,807,582 股(占公司总股本 4.77%)。具体内容详见公司于 2024 年 5 月 22 日披露的《关于股份回购实施结果暨股份变动的公告》(公告编号:2024-037 号)。 减持计划的进展情况 2025 年 10 月 30 日,公司披露了《金花企业(集团)股份有限公司关于回 购股份集中竞价减持计划的公告》(公告编号:2025-044 号),自前述 ...
金花股份:已减持0.0054%股份,成交总额16.9万元
Xin Lang Cai Jing· 2026-02-13 07:57
金花股份公告,已按减持计划于2026年2月11日首次通过集中竞价减持回购股份20000股,占总股本 0.0054%,减持均价8.45元/股,成交总额16.9万元。减持后回购专用证券账户持有股份2053.76万股,占 5.50%。此前公司2024年2月23日至5月22日期间累计回购2055.76万股,占5.51%,并计划自2025年10月 30日起6个月内减持不超746.54万股(2%)。 ...
金花股份(600080) - 金花企业(集团)股份有限公司关于集中竞价减持已回购股份的进展公告
2026-02-03 09:01
证券代码:600080 证券简称:金花股份 公告编号:2026-005 金花企业(集团)股份有限公司 关于集中竞价减持已回购股份的进展公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 回购股份的基本情况 金花企业(集团)股份有限公司(以下简称"公司")于 2024 年 2 月 23 日 至 2024 年 5 月 22 日期间通过集中竞价交易方式累计回购公司股份 20,557,582 股,占公司总股本的 5.51%。其中,用于员工持股计划或股权激励累计回购股份 2,750,000 股(占公司总股本 0.74%);用于维护公司价值及股东权益累计回购股 份 17,807,582 股(占公司总股本 4.77%)。具体内容详见公司于 2024 年 5 月 22 日披露的《关于股份回购实施结果暨股份变动的公告》(公告编号:2024-037 号)。 减持计划的进展情况 2025 年 10 月 30 日,公司披露了《金花企业(集团)股份有限公司关于回 购股份集中竞价减持计划的公告》(公告编号:2025-044 号 ...
金花股份:2025年净利润预同比减少81.24%到73.19%
Zheng Quan Ri Bao Zhi Sheng· 2026-01-23 14:20
Core Viewpoint - The company, Jinhua Co., Ltd., expects a significant decrease in net profit for the fiscal year 2025, projecting a range of 14 million to 20 million yuan, which represents a substantial decline compared to the previous year's profit of 74.6113 million yuan [1] Financial Performance - The projected net profit for 2025 is estimated to be between 14 million yuan and 20 million yuan [1] - This represents a decrease of 60.6113 million yuan to 54.6113 million yuan compared to the previous year [1] - The year-on-year decline in net profit is expected to be between 81.24% and 73.19% [1]
金花股份(600080.SH):预计2025年度净利润同比减少81.24%到73.19%
Ge Long Hui A P P· 2026-01-23 10:04
Core Viewpoint - The company Jin Hua Co., Ltd. (600080.SH) expects a significant decline in net profit for the fiscal year 2025, projecting a decrease of 73.19% to 81.24% compared to the previous year [1] Financial Projections - The estimated net profit attributable to the parent company for 2025 is projected to be between 14 million to 20 million yuan [1] - The estimated net profit after deducting non-recurring gains and losses is expected to be between 12 million to 17 million yuan, reflecting a year-on-year change of -12.89% to 23.41% [1] Comparison with Previous Year - The decrease in net profit is primarily due to the previous year's gain from the disposal of a wholly-owned subsidiary, Jin Hua International Hotel Co., Ltd., which contributed an investment income of 34.33 million yuan [1] - The difference between the initial cost of the equity in Jin Hua International Hotel Co., Ltd. and its book value at the time of disposal also led to a reduction in income tax expenses by 39.00 million yuan in the previous year [1]
金花股份:预计2025年度净利润同比减少81.24%到73.19%
Ge Long Hui· 2026-01-23 10:02
Core Viewpoint - The company Jin Hua Co., Ltd. (600080.SH) expects a significant decline in net profit for the fiscal year 2025, projecting a decrease of 73.19% to 81.24% compared to the previous year [1] Financial Projections - The estimated net profit attributable to the parent company's owners for 2025 is projected to be between 14 million to 20 million yuan [1] - The estimated net profit after deducting non-recurring gains and losses is expected to be between 12 million to 17 million yuan, reflecting a year-on-year change of -12.89% to 23.41% [1] Previous Year Comparison - The decrease in net profit is primarily attributed to the previous year's disposal of 100% equity in its wholly-owned subsidiary, Jin Hua International Hotel Co., Ltd., which resulted in an investment income of 34.33 million yuan [1] - The difference between the initial cost of the equity in Jin Hua International Hotel Co., Ltd. and its book value at the time of disposal led to an increase in the company's tax-deductible income, reducing the income tax expense by 39.00 million yuan in the previous year [1]
金花股份(600080) - 2025 Q4 - 年度业绩预告
2026-01-23 09:50
Financial Performance - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between 14 million and 20 million yuan, representing a decrease of 73.19% to 81.24% compared to the previous year[3]. - The estimated net profit after deducting non-recurring gains and losses for 2025 is projected to be between 12 million and 17 million yuan, with a year-on-year change of -12.89% to 23.41%[4]. - The previous year's net profit attributable to shareholders was 74.61 million yuan, with a total profit of 42.04 million yuan[5]. - The decrease in net profit is primarily due to the previous year's gain from the disposal of a subsidiary, which contributed 34.33 million yuan to investment income[7]. - The company reported earnings per share of 0.2088 yuan in the previous year[6]. Government Support - Government subsidies received by the company have decreased compared to the previous year[7]. Risk Management - The company has resolved the risk related to illegal guarantees by the former actual controller, with a guarantee deposit of 21.90 million yuan paid by the controlling shareholder and some directors[8]. Financial Reporting - The financial data provided is preliminary and subject to final audited results in the 2025 annual report[9].
金花股份涨2.08%,成交额2197.16万元,主力资金净流入17.88万元
Xin Lang Cai Jing· 2026-01-19 03:00
Group 1 - The core viewpoint of the news is that Jinhua Co., Ltd. has shown fluctuations in its stock price and financial performance, with a recent increase in stock price and mixed performance in revenue and profit [1][2]. Group 2 - As of January 19, Jinhua's stock price increased by 2.08% to 7.86 CNY per share, with a total market capitalization of 2.934 billion CNY [1]. - Year-to-date, Jinhua's stock price has risen by 4.24%, but it has experienced a decline of 1.26% over the last five trading days and 1.38% over the last twenty days [2]. - The company reported a revenue of 384 million CNY for the first nine months of 2025, a year-on-year decrease of 8.36%, while the net profit attributable to shareholders was 34.4812 million CNY, an increase of 12.06% [2]. Group 3 - Jinhua Co., Ltd. has a primary business focus on the research, production, and sales of pharmaceuticals, with 99.71% of its revenue coming from drug sales [2]. - The company has distributed a total of 118 million CNY in dividends since its A-share listing, with 10.5814 million CNY distributed over the past three years [3].
中药板块1月8日涨0.31%,沃华医药领涨,主力资金净流出4.93亿元
Zheng Xing Xing Ye Ri Bao· 2026-01-08 08:51
Market Overview - The Traditional Chinese Medicine (TCM) sector saw a slight increase of 0.31% on January 8, with WoHua Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Top Performers - WoHua Pharmaceutical (002107) closed at 7.13, up 5.63% with a trading volume of 298,400 shares and a turnover of 210 million yuan [1] - Enwei Pharmaceutical (301331) closed at 29.06, up 5.52% with a trading volume of 29,600 shares and a turnover of 85 million yuan [1] - Jinhua Co., Ltd. (600080) closed at 8.03, up 4.69% with a trading volume of 137,600 shares and a turnover of 110 million yuan [1] Underperformers - Jilin Aodong (000623) closed at 20.04, down 2.48% with a trading volume of 206,000 shares and a turnover of 416 million yuan [2] - Panlong Pharmaceutical (002864) closed at 34.32, down 1.58% with a trading volume of 149,000 shares and a turnover of 524 million yuan [2] - RY Pharmaceutical (600332) closed at 25.04, down 1.57% with a trading volume of 486,000 shares and a turnover of 122 million yuan [2] Capital Flow - The TCM sector experienced a net outflow of 493 million yuan from institutional investors, while retail investors saw a net inflow of 378 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are actively buying [2] Individual Stock Capital Flow - Huaren Sanjiu (6660000) had a net inflow of 57.91 million yuan from institutional investors, while it faced a net outflow of 51.38 million yuan from speculative funds [3] - Yunnan Baiyao (000538) saw a net inflow of 42.56 million yuan from institutional investors, but also experienced outflows from both speculative and retail investors [3] - Wanbangde (002082) had a net inflow of 26.36 million yuan from institutional investors, with outflows from speculative and retail investors [3]